These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33019903)

  • 1. The role of aspirin in the prevention of ovarian, endometrial and cervical cancers.
    Joharatnam-Hogan N; Cafferty FH; Macnair A; Ring A; Langley RE
    Womens Health (Lond); 2020; 16():1745506520961710. PubMed ID: 33019903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis.
    Verdoodt F; Kjaer SK; Friis S
    Maturitas; 2017 Jun; 100():1-7. PubMed ID: 28539172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.
    Setiawan VW; Matsuno RK; Lurie G; Wilkens LR; Carney ME; Henderson BE; Kolonel LN; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1441-9. PubMed ID: 22665579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Aspirin Use Reduce the Risk for Ovarian Cancer?
    Micha JP; Rettenmaier MA; Bohart RD; Goldstein BH
    Cancer Invest; 2024 Aug; 42(7):643-646. PubMed ID: 38965997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.
    Brasky TM; Moysich KB; Cohn DE; White E
    Gynecol Oncol; 2013 Jan; 128(1):113-119. PubMed ID: 23063765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Does tubal sterilization reduce the risk of gynaecological cancers?
    Purdie DM
    Int J Epidemiol; 2004 Jun; 33(3):603-4. PubMed ID: 15163643
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin and NSAIDs: effects in breast and ovarian cancers.
    Crew KD; Neugut AI
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of gynecologic cancers.
    Grimes DA; Economy KE
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):227-35. PubMed ID: 7847546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic medication use and risk of epithelial ovarian cancer in African American women.
    Peres LC; Camacho F; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry P; Wang F; Schildkraut JM
    Br J Cancer; 2016 Mar; 114(7):819-25. PubMed ID: 26908324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception and chemoprevention of female cancers.
    Pike MC; Spicer DV
    Endocr Relat Cancer; 2000 Jun; 7(2):73-83. PubMed ID: 10903525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for Chemoprevention of Cancers of the Cervix, Endometrium and Ovary: Surrogate Endpoints and Design of Clinical Trials. Conference proceedings. Oxnard, California, February 1-5, 1995.
    J Cell Biochem Suppl; 1995; 23():1-250. PubMed ID: 8786651
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
    Cuzick J; Otto F; Baron JA; Brown PH; Burn J; Greenwald P; Jankowski J; La Vecchia C; Meyskens F; Senn HJ; Thun M
    Lancet Oncol; 2009 May; 10(5):501-7. PubMed ID: 19410194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Use and Risk of Ovarian Cancer: More Player Pathways for a Common Starting Point?
    Mormile R
    Cancer Invest; 2019; 37(8):415-416. PubMed ID: 31446811
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
    Wilson JC; O'Rorke MA; Cooper JA; Murray LJ; Hughes CM; Gormley GJ; Anderson LA
    Cancer Epidemiol; 2013 Dec; 37(6):897-904. PubMed ID: 24042024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of aspirin in preventing colorectal cancer.
    Burn J; Sheth H
    Br Med Bull; 2016 Sep; 119(1):17-24. PubMed ID: 27543497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.
    Trabert B; Poole EM; White E; Visvanathan K; Adami HO; Anderson GL; Brasky TM; Brinton LA; Fortner RT; Gaudet M; Hartge P; Hoffman-Bolton J; Jones M; Lacey JV; Larsson SC; Mackenzie GG; Schouten LJ; Sandler DP; O'Brien K; Patel AV; Peters U; Prizment A; Robien K; Setiawan VW; Swerdlow A; van den Brandt PA; Weiderpass E; Wilkens LR; Wolk A; Wentzensen N; Tworoger SS;
    J Natl Cancer Inst; 2019 Feb; 111(2):137-145. PubMed ID: 29860330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive strategies for reducing the risk of reproductive cancers.
    Aliabadi AR; Wilailak S; McNally O; Berek JS; Sridhar A; ;
    Int J Gynaecol Obstet; 2024 Jul; 166(1):141-151. PubMed ID: 38725288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
    Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
    Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
    Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
    Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.